Company’s 36-month beta value is 1.69.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AEMD is 8.61M, and currently, short sellers hold a 5.26% ratio of that floaft. The average trading volume of AEMD on June 25, 2024 was 4.29M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
AEMD) stock’s latest price update
The stock price of Aethlon Medical Inc (NASDAQ: AEMD) has jumped by 2.04 compared to previous close of 0.63. Despite this, the company has seen a fall of -0.09% in its stock price over the last five trading days. prnewswire.com reported 2024-06-21 that SAN DIEGO, June 21, 2024 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal year ended March 31, 2024, at 4:15 p.m. ET on Thursday, June 27, 2024.
AEMD’s Market Performance
Aethlon Medical Inc (AEMD) has experienced a -0.09% fall in stock performance for the past week, with a 56.10% rise in the past month, and a -63.22% drop in the past quarter. The volatility ratio for the week is 14.88%, and the volatility levels for the past 30 days are at 18.51% for AEMD. The simple moving average for the past 20 days is 19.72% for AEMD’s stock, with a -60.41% simple moving average for the past 200 days.
AEMD Trading at -28.15% from the 50-Day Moving Average
After a stumble in the market that brought AEMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -87.20% of loss for the given period.
Volatility was left at 18.51%, however, over the last 30 days, the volatility rate increased by 14.88%, as shares surge +58.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -55.96% lower at present.
During the last 5 trading sessions, AEMD rose by +3.81%, which changed the moving average for the period of 200-days by -75.37% in comparison to the 20-day moving average, which settled at $0.5468. In addition, Aethlon Medical Inc saw -70.78% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for AEMD
Current profitability levels for the company are sitting at:
- -21.99 for the present operating margin
- -6210.47 for the gross margin
The net margin for Aethlon Medical Inc stands at -21.31. The total capital return value is set at -1.51. Equity return is now at value -98.43, with -78.62 for asset returns.
Based on Aethlon Medical Inc (AEMD), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at -10.41. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 1150.87.
Currently, EBITDA for the company is -11.76 million with net debt to EBITDA at 0.0. When we switch over and look at the enterprise to sales, we see a ratio of -1.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.93.
Conclusion
In a nutshell, Aethlon Medical Inc (AEMD) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
